The authors assess use of the novel assistant physician (AP) pathway and examine Missouri regulatory changes. They find limited supply impacts of APs and discuss implications.
David Schwartzman, PhD
Advertisement
Articles by David Schwartzman, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Ebola Cases Top 1700 as Unpaid Health Workers Strike
2
FDA Approves Atacicept for IgA Nephropathy
3
340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs
4
Quest Adds Haystack MRD to OncoEMR for Community Oncology
5